慢性肾脏病进展中的慢性炎症:Nrf2的作用
本综述阐述慢性炎症、氧化应激、缺氧、衰老和线粒体功能障碍等中间表型在慢性肾脏病(CKD)病因、进展和病理生理中的关键作用。NF-κB和Nrf2分别调控促炎和抗炎因子基因转录,在肾小球和肾小管细胞对肾损伤的反应中起重要作用。慢性炎症促进CKD中肾小球滤过率(GFR)下降,并在Alport综合征、常染色体显性多囊肾病(ADPKD)、IgA肾病(IgAN)和局灶节段性肾小球硬化(FSGS)等疾病中导致纤维化和终末期肾病(ESKD)。
要点
- 慢性炎症通过NF-κB和Nrf2转录调控参与CKD进展。
- 慢性炎症促进CKD中GFR下降并导致纤维化和ESKD。
- Nrf2是调控抗炎因子基因转录的关键因子。
核心结论
- 慢性炎症是CKD进展的关键病理生理机制,Nrf2调控的抗炎通路在其中起重要作用。
研究设计与样本
- 本文为综述,旨在阐明慢性炎症在多种肾脏疾病病理生理和疾病进展中的机制,重点关注Nrf2。
主要发现
- 慢性炎症、氧化应激、缺氧、衰老和线粒体功能障碍作为中间表型在CKD病因、进展和病理生理中起关键作用。
- NF-κB和Nrf2分别调控促炎和抗炎因子基因转录,在肾小球和肾小管细胞对肾损伤的反应中起关键作用。
- 慢性炎症促进CKD中GFR下降。
- 在Alport综合征、ADPKD、IgAN和FSGS等疾病中,未解决的炎症过程导致纤维化和终末期肾病(ESKD)。
临床怎么用
- 关注慢性炎症作为CKD进展的治疗靶点,Nrf2通路可能为干预方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite recent advances in the management of chronic kidney disease (CKD), morbidity and mortality rates in these patients remain high. Although pressure-mediated injury is a well-recognized mechanism of disease progression in CKD, emerging data indicate that an intermediate phenotype involving chronic inflammation, oxidative stress, hypoxia, senescence, and mitochondrial dysfunction plays a key role in the etiology, progression, and pathophysiology of CKD. A variety of factors promote chronic inflammation in CKD, including oxidative stress and the adoption of a proinflammatory phenotype by resident kidney cells. Regulation of proinflammatory and anti-inflammatory factors through NF-κB- and nuclear factor, erythroid 2 like 2 (Nrf2)-mediated gene transcription, respectively, plays a critical role in the glomerular and tubular cell response to kidney injury. Chronic inflammation contributes to the decline in glomerular filtration rate (GFR) in CKD. Whereas the role of chronic inflammation in diabetic kidney disease (DKD) has been well-elucidated, there is now substantial evidence indicating unresolved inflammatory processes lead to fibrosis and eventual end-stage kidney disease (ESKD) in several other diseases, such as Alport syndrome, autosomal-dominant polycystic kidney disease (ADPKD), IgA nephropathy (IgAN), and focal segmental glomerulosclerosis (FSGS). In this review, we aim to clarify the mechanisms of chronic inflammation in the pathophysiology and disease progression across the spectrum of kidney diseases, with a focus on Nrf2.
引用
- Stenvinkel P, Chertow GM, Devarajan P, et al. Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2. Kidney Int Rep. 2021. PMID: 34307974. doi:10.1016/j.ekir.2021.04.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。